Navigation Links
Paul Sullivan's Legacy: An Early Warning Program for Detecting Melanoma Before It's Too Late
Date:10/9/2008

Leading Melanoma Specialists Will Give Accredited Course for Non-Dermatologists about Detection and Management of Melanoma

To be held November 1, 2008 at the Royal Sonesta Hotel Boston, Cambridge, MA

CONCORD, Mass., Oct. 9 /PRNewswire-USNewswire/ -- The Melanoma Foundation of New England and the Boston University School of Medicine are co-sponsoring an Accreditation Council for Continuing Medical Education (ACCME) course to update non-dermatologists on the detection and management of melanoma. The course is given through the Foundation's Paul Sullivan Melanoma Institute developed to educate healthcare providers in the early detection and management of melanoma, in an effort to reduce the devastating effects of the disease. Paul Sullivan, a columnist for the Lowell Sun and a talk show host at WBZ radio, lost his battle with melanoma in 2007. Paul was an advocate for early detection of skin cancer and melanoma.

Melanoma, the most deadly form of skin cancer, is nearly 100% treatable if detected early. However, if it is not, melanoma is likely to spread to other parts of the body where it becomes hard to treat and can be fatal. It was Paul Sullivan's strong belief that the best way to combat melanoma deaths is by training health care professionals who see our skin to give us more regular and effective skin examinations. Paul was a great supporter of the Foundation and became closely involved with our programs toward the end of his life.

"According to a recent survey, 23% of graduating medical students had never observed skin cancer examinations, 26.7% had received no training, and 43.4% had never performed the examination. Fifty-seven percent had spent no time in a dermatology clinic," says Deb Girard, Executive Director of the Melanoma Foundation of New England. "This course is intended specifically to provide pertinent information to the non-dermatologist about identifying patients at risk for melanoma, providing counseling for high-risk patients, as well as screening for early melanoma."

Family physicians, primary care internists, geriatricians, obstetricians, gynecologists, nurse practitioners, residents, physician assistants, and fellow should attend. Speakers include: Alan C. Geller, M.P.H., R.N., Research Associate Professor of Dermatology and Epidemiology, Boston University School of Medicine, Boston University School of Public Health; Hensin Tsao, M.D., Ph.D., Director, MGH Melanoma and Pigmented Lesion Center, Director, MGH Melanoma Genetics Program, Massachusetts General Hospital, Associate Professor of Dermatology Harvard Medical School; Marie-Grance Demierre, M.D., Associate Professor of Dermatology, Boston University School of Medicine; Martin A. Weinstock, M.D., Ph.D., Professor of Dermatology and Community Health, Brown University.

To register for the course or for more information visit http://www.mfne.org or http://www.bu.edu/cme, call 617-638-4605 or email cme@bu.edu.

The Melanoma Foundation of New England is a non-profit organization dedicated to educating the public about the importance of early detection and prevention, and helping patients and their caregivers cope with melanoma. Skin cancer is the number one diagnosed cancer in the United States. Melanoma is the most preventable cancer. The Foundation was founded in 1999 and is a 501(c)(3) non-profit organization that provides educational programs, support groups, and advocacy for melanoma patients. Learn more about the Foundation at: http://www.mfne.org.


'/>"/>
SOURCE Melanoma Foundation of New England
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hillary Clintons Legacy: Health Insurance Truth
2. Husband Seeks Votes for Alzheimers Disease: Early Detection Matters Project
3. U.S. Department of Labor announces $1.2 million grant to provide nearly 700 North Carolina workers with health insurance payments as part of Trade Adjustment Assistance benefits
4. The Market for Disease-Modifying Osteoarthritis Drugs Will Experience Exponential Growth, Increasing From $477 Million in 2007 to Nearly $3.8 Billion in 2017
5. Early Mobility Best for ICU Patients
6. 2nd International Conference, Signs of Autism in Infants: Changing Outcomes Through Early Identification and Intervention, October 11 & 12, 2008; Unique and Critical Event
7. Autism Speaks, CDC and The Advertising Council Launch Program to Educate Teachers About Importance of Early Intervention for Autism
8. Early Breast Cancer No More Likely to Return in Young Women
9. Yearly Premiums for Family Health Coverage Rise to $12,680 in 2008, Up 5 Percent, As Many Workers Also Face Higher Deductibles
10. Troubled girls from poor neighborhoods more likely to have sex in early adolescence
11. PA Governor Rendell Announces Nearly $750,000 Investment in Nurse Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: